Carson Advisory Inc. Novo Nordisk A S Transaction History
Carson Advisory Inc.
- $145 Million
- Q2 2025
A detailed history of Carson Advisory Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Carson Advisory Inc. holds 4,498 shares of NVO stock, worth $246,400. This represents 0.21% of its overall portfolio holdings.
Number of Shares
4,498Holding current value
$246,400% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,710Shares Held
312MCall Options Held
13.7MPut Options Held
19.7M-
Jennison Associates LLC18.9MShares$1.03 Billion0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$806 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$783 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$689 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$637 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $124B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...